Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia
Clinical trial NCT04234698 · COMPLETED
Trial details
- NCT number
- NCT04234698
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-22
- Primary completion
- 2021-10-31
- Enrollment
- 2076
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.